Cite
APA Citation
D'Urzo, A., van Noord, J. A., Martin, C., Horton, R., Banerji, D., Lu, Y., Alagappan, V. K. T., & Overend, T. (n.d.). p252 Once-daily NVA237 improves symptoms, and reduces COPD exacerbations and associated hospitalisations: the GLOW1 trial. Thorax, 66, A170. http://access.bl.uk/ark:/81055/vdc_100144719229.0x000035